A consent form template for phase I oncology trials

IRB Ethics and Human Research

Volumn 31, Issue 4, 2009, Pages 1-5

  Koyfman, Shlomo A ^a   Mccabe, Mary S ^b   Emanuel, Ezekiel J ^c   Grady, Christine ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPREHENSION; ETHICS; HUMAN; INFORMED CONSENT; MEDICAL RESEARCH; NEOPLASM; ORGANIZATION AND MANAGEMENT; PHASE 1 CLINICAL TRIAL; READING; STANDARD; UNITED STATES;

BIOMEDICAL RESEARCH; CLINICAL TRIALS, PHASE I AS TOPIC; COMPREHENSION; CONSENT FORMS; HUMANS; INFORMED CONSENT; NEOPLASMS; READING; UNITED STATES;

EID: 68649114616     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Daugherty CK. Impart of therapeutic research on informed consent and the ethics of clinical trials: A medical oncology perspective. Journal of Clinical Oncology 1999;17(5):1601-1617;
2. Grossman SA, Piantadosi S, Covahey C. Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families? Journal of Clinical Oncology 1994;12(10):2211-2215;
3. Horng S, Emanuel EJ, Wilfond B, et al. Descriptions of benefits and risks in consent forms for phase I oncology trials. NEJM 2002;347(26):2134-2140;
4. Joseph RR. Viewpoints and concerns of a clinical trial participant. Cancer 1994;74(9 Suppl):2692-2693;
5. Meade CD, Howser DM. Consent forms: How to determine and improve their readability. Oncology Nursing Forum 1992;19(10):1523-1528;
6. Davis TC, Holcombe RF, Berkel HJ, et al. Informed consent for clinical trials: A comparative study of standard versus simplified forms. Journal of the National Cancer Institute 1998;90(9):668-674.
7. See ref. 1, Horng et al. 2002.
8. See ref. 1, Dougherty 1999.
9. Bjorn E, Rossel P, Holm S. Can the written information to research subjects be improved? An empirical study. Journal of Medical Ethics 1999;25(3):263-267;
10. Paasche-Orlow MK, Taylor HA, Brancati FL. Readability standards for informed-consent forms as compared with actual readability. NEJM 2003;348(8):721-726;
11. Simes RJ, Tattersall MH, Coates AS, et al. Randomized comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer. British Medical Journal (Clinical Research Edition) 1986;293(6554):1065-1068;
12. Taylor KM, Bezjak A, Hunter R, Fraser S. Informed consent for clinical trials: Is simpler better? Journal of the National Cancer Institute 1998;90(9):644-645;
13. Dresden GM, Levitt MA. Modifying a standard industry clinical trial consent form improves patient information retention as part of the informed consent process. Academic Emergency Medicine 2001;8(3):246-252.
14. http://www.cancer.gov/clinical-trials/doc-header.aspx?viewid= 5fca4dc5-b6a7-4272-be96-b489f23022e5&docid=61f9435e-c529-42fa-81a5- fc6ecd30d42e.
15. Miller M. Phase I cancer trials. A collusion of misunderstanding. Hastings Center Report 2000;30(4):34-43;
16. Agrawal M, Emanuel EJ. Ethics of phase I oncology studies: Reexamining the arguments and data. JAMA 2003;290(8):1075-1082;
17. Emanuel EJ. A phase I trial on the ethics of phase I trials. Journal of Clinical Oncology 1995;13(5): 1049-1051.
18. See ref. 6, Agrawal and Emanuel 2003.
19. See ref. 1, Horng et al. 2002.
20. See ref. 6, Agrawal and Emanuel 2003.
21. Shalowitz D, Wendler D. Informed consent for research and authorization under the Health Insurance Portability and Accountability Act Privacy Rule: An integrated approach. Annals of Internal Medicine 2006;144(9):685-688.
22. Wendler D. One-time general consent for research on biological samples. BMJ 2006;332(7540):544-547.
23. Horstmann E, McCabe MS, Grochow L, et al. Risks and benefits of phase I oncology trials, 1991 through 2002. NEJM 2005;352(9):895-904;
24. Roberts TG, Jr., Goulart BH, Squitieri L, et al. Trends in the risks and benefits to patients with cancer participating in phase I clinical trials. JAMA 2004;292(17):2130-3140.
25. http://www.online-utility.org/english/readability-test-and-improve.jsp.
26. Flesch R. A new readability yardstick. Journal of Applied Psychology 1948;32:2211-2223;
27. Glinsky A. How valid is the Flesch readability formula? American Psychologist 1948;3:261;
28. Gunning R. The Fog index after twenty years. Journal of Business Communication 1968;6:3-13.
29. See ref. 1, Daugherty 1999;
30. Grossman et al. 1994.
31. http://www.standards-schmandards.com/exhibits/rix/index.php.
32. Heinze-Lacey B, Saunders C, Sugar A. Improving the readability of informed consent documents. IRB: A Review of Human Subjects Research 1993;15(3):10-11.
33. See ref. 4, Dresden and Levitt 2001;
34. Sharp SM. Consent documents for oncology trials: Does anybody read these things? American Journal of Clinical Oncology 2004;27(6):570-575.